"Diet pill "Zhaji" reduces costs and Pfizer (PFE.US) Q1 profits exceed expectations but revenue declines"

According to the Securities Times APP, on Tuesday, Pfizer (PFE.US) released its first quarter performance before the market opening on Tuesday, intensifying cost reduction efforts this quarter, and profits exceeded market expectations. However, despite this, overall revenue of the company still declined due to the shattered vision of weight loss drugs and a decrease in revenue from COVID-19 related products.